Wider Fentora Use Could Encourage Abuse: FDA
Expanding the approved use of Cephalon Inc.'s Fentora pain reliever beyond cancer patients could lead to increased abuse and misuse of the drug, a U.S. Food and Drug Administration official said...To view the full article, register now.
Already a subscriber? Click here to view full article